Home › Funds › Venrock Adviser, LLC › VOR

Venrock Adviser, LLC position in VOR

VOR BIOPHARMA INC COM NEW · Health Care

Venrock Adviser, LLC reported holding 3,041,719 shares of VOR (VOR BIOPHARMA INC COM NEW) in its Q2 2026 13F filing — a position valued at US$56.0M, representing 1.70% of its reported portfolio and ranking #12 among its reported holdings. Venrock Adviser, LLC has disclosed VOR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)3.04M sh
Reported value held$56.00M
Portfolio Weight1.70%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's VOR position evolved

Venrock Adviser, LLC first disclosed a stake in VOR in Q3 2025 at 499,966 shares (US$24.4M). The position peaked in Q2 2026 at 3,041,719 shares, worth US$56.0M. Across 4 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,041,719 shares valued at US$56.0M. Notable position changes include a 289% increase in Q4 2025 (shares rose 36% over the following quarter), a 56% increase in Q1 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 499.97K $24.36M New
Q4 2025 1.94M $25.42M Add
Q1 2026 3.04M $54.26M Add
Q2 2026 3.04M $56.00M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VOR and 13F data

VOR (VOR BIOPHARMA INC COM NEW) is a Health Care company. 75 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$104.4M), FCPM III SERVICES B.V. (US$75.8M), Frazier Life Sciences Management, L.P. (US$46.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VOR

All VOR fund holders →

FAQ

How long has Venrock Adviser, LLC held VOR?

Venrock Adviser, LLC has disclosed VOR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Venrock Adviser, LLC's current position in VOR?

As of Q2 2026, Venrock Adviser, LLC holds 3.04M shares of VOR (VOR BIOPHARMA INC COM NEW), valued at $56.00M, representing 1.70% of its reported portfolio and ranking #12.

Has Venrock Adviser, LLC been buying or selling VOR?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in VOR. The position peaked in Q2 2026 at 3.04M shares.

Which other funds hold VOR?

Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Frazier Life Sciences Management, L.P., among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.